-+ 0.00%
-+ 0.00%
-+ 0.00%

Bicara Therapeutics files initial beneficial ownership statement for CMO William Schelman

PUBT·05/12/2026 20:03:13
Listen to the news
Bicara Therapeutics files initial beneficial ownership statement for CMO William Schelman
  • Bicara Therapeutics Chief Medical Officer William Schelman reported stock options for 175,000 shares, including 150,000 at USD 16.61 and 25,000 at USD 16.76, in an initial Form 3 filing.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bicara Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-034079), on May 12, 2026, and is solely responsible for the information contained therein.